IMO, it will be difficult for CYDY to go cancer alone because even with HIV moving forward, they may not make enough cash soon enough to fund a marketing and sales for for cancer. Some are saying that leronlimab could be approved for cancer in 2020 if results are consistent, which would be before CYDY would see large enough returns for HIV.